CONTACT: RACHEL BALLWEG
8788 John Pappajohn Pavilion
Iowa City IA 52242
Release: Nov. 17, 2000
Gingrich named associate director for clinical services at UI's Holden
IOWA CITY, Iowa -- Officials with the Holden Cancer Center at the University
of Iowa today announced the appointment of Roger Gingrich, M.D., Ph.D., as
the center's associate director for clinical services.
George Weiner, M.D., director of the Holden Cancer Center, created the new
associate director position in order to coordinate the interactions between
the Holden Cancer Center and referring physicians in the community. Gingrich
will also oversee clinical activities in the John and Mary Pappajohn Clinical
Cancer Center, the Cancer Information Service, and the Oncology Registry.
"My hope is to create an atmosphere where people who are clinically
oriented -- either in education, research or patient care -- feel empowered
to dream and brainstorm with each other about how this Cancer Center can become
the best possible place for Iowans and others to come for cancer care,"
Gingrich said, "especially when those needs can't be met in their local
"We are pleased that Dr. Gingrich accepted the associate director position,"
Weiner said in a letter to faculty and staff of University of Iowa Health
Care. "In his current role as director of the Adult Bone Marrow Transplantation
Program, he has gained extensive experience in the management of a complex
clinical program, and he has developed outstanding relationships with community
"The possibilities for exploring and developing our cancer care to
be the very best it can be are what attracted me to this position," Gingrich
said. "There are three areas of development that will be my initial priorities.
These include multidisciplinary oncology care, interaction with referring
physicians who do oncology, and management of quality."
Gingrich pointed out that the Holden Cancer Center staff already provides
high quality care, research and education but he sees potential for even greater
achievements. Gingrich plans to meet with the clinical faculty and staff to
discuss the progress of the Holden Cancer Center team in an open, collaborative,
process-oriented forum. The goal is to evaluate the center's strengths and
identify areas for improvement.
"We all know that we do a great job," Gingrich said. "but
how do we measure that and improve on it? Without a doubt, all of what we
do will require that we work as a team in successfully executing our mission."
Gingrich will offer his e-mail address as a suggestion box for faculty and
staff to offer input about changes they'd like to see made and hopes they
have for the future of the Holden Cancer Center.
Gingrich said he will continue in his current role as director of Adult
Bone Marrow Transplantation, but will focus an increasing amount of his attention
on his new position.
Last July, the Holden Cancer Center was awarded the prestigious National
Cancer Institute seal of approval. This designation as an NCI Cancer Center
places University of Iowa Health Care among the highest in the field. The
Holden Cancer Center is the only NCI-designated center in Iowa, and one of
only 33 in the United States.
University of Iowa Health Care describes the partnership between
the UI College of Medicine and the UI Hospitals and Clinics and the patient
care, medical education and research programs and services they provide.